Riskpilot← Back to searchSign inGet full accessMedLed AB
ABActiveOrg 5591088835Linnegatan 2Other education n.e.c. · NACE 8559Est. 20171 employees
Revenue 2025
SEK 52K
-97% vs 2024
EBITDA margin
1.5%
-100% vs 2024
Equity ratio
58.6%
Financial strength
Net profit 2025
SEK 85K
-89% vs 2024
| Revenue | SEK 52K | -97% |
| EBITDA | SEK 791 | -100% |
| Net profit | SEK 85K | -89% |
| Total assets | SEK 2,8M | -16% |
| Equity | SEK 1,7M | -7% |
| Employees | 1 | — |
Legal name
MedLed AB
Org number
5591088835
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
13 april 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall äga och förvalta aktier, bedriva konsultverksamhet inom ledarskap och försäljning och därmed förenlig verksamhet.
Address
Linnegatan 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 757 | 1 577 | 3 081 | 1 728 | 52 |
| Staff expenses | — | −262 | −920 | −151 | −6 |
| EBITDA | 420 | 1 083 | 1 116 | 1 282 | 1 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 420 | 1 083 | 1 116 | 1 282 | 1 |
| Net financials | — | −24 | 26 | 11 | 89 |
| Profit before tax | 313 | 787 | 882 | 963 | 90 |
| Tax | −66 | −168 | −186 | −204 | −5 |
| Net profit | 247 | 619 | 696 | 759 | 85 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 995 | 1 942 | 5 057 | 3 371 | 2 838 |
| Equity | 422 | 832 | 1 318 | 1 786 | 1 662 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 271 | 538 | 2 908 | 422 | 14 |
| Total debt | 271 | 538 | 2 908 | 422 | 14 |
EBITDA margin
1.5%
This company
15.8%
Market median
-91% vs market
20212025
Equity ratio
58.6%
This company
38.2%
Market median
+53% vs market
20212025
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
20212025
Net profit margin
165.0%
This company
8.1%
Market median
+1937% vs market
20212025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20212025
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedLed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Viveka Madelene Malmquist Johansson | Board of Directors | 0 companies |
| Lars Greger Johansson | Deputy Board Member | 0 companies |
| Iréne Ann-Kristin Eriksson | Deputy Board Member | 0 companies |